We are backed by some of the highest quality private equity investors in the world. Our financial backers are not just investors. More importantly, they are our partners.

TPG, Montreux Equity Partners and Votorantim provide significant value to moksha8 through their strong global and local networks to support our vision to bring the highest quality medical products and services to the Emerging Markets.

TPG Biotech, is the venture capital investment platform of TPG, the global private investment firm with over $50 billion of capital under management. Since the firm's founding in 1992, its investment philosophy has been to create value by investing in change - change created by industry trends, economic cycles or specific company circumstances. TPG invests in companies across a broad range of industries and geographies.

TPG Biotech makes venture capital investments in companies in biotechnology and related life sciences. Its goal is to help management teams build long-term value that benefits all stakeholders.

Votorantim Novos Negocios is the Venture Capital and Private Equity arm of Votorantim, one of the largest private industrial conglomerates in Latin America. Votorantim Novos Negocios invests in companies with significant growth potential and contributes actively in value creation through the involvement in the strategy and management of the company.

Montreux Equity Partners, based in Menlo Park, CA, is a life sciences focused venture capital firm that invests in pharmaceutical and medical device companies. Montreux's goal is to generate significant capital gains for both our investors and the entrepreneurs that we support. Montreux is currently investing out of our fourth fund, MEP IV, a $250 M fund. The firm's investment team brings more than 70 years of operating and investing experience as entrepreneurs, managers and investors of life sciences focused companies.